Advertisement
Advertisement

MGX

MGX logo

Metagenomi, Inc. Common Stock

1.44
USD
+0.01
+0.35%
Jun 16, 15:59 UTC -4
Closed
exchange

After-Market

1.46

+0.03
+2.02%

Metagenomi, Inc. Common Stock Profile

About

Metagenomi Inc. is a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived gene editing toolbox. Metagenomi Inc. is based in EMERYVILLE, Calif.

Info & Links

CEO

Brian C. Thomas

Headquarters

5959 HORTON STREET, 7TH FLOOR
EMERYVILLE, CA 94608, UNITED STATES

Sector

Medical

Auditor

PricewaterhouseCoopers LLP

Share holders

221

Employees

202

Metagenomi, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

54.73M

Enterprise Value

25.53M

Enterprise Value/EBITDA(ttm)

-0.28

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.66

Price to Book(mrq)

0.36

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-130.54%

Profit Margin(ttm)

-266.70%

Return on Equity(ttm)

-43.23%

Return on Invested Capital(ttm)

-33.06%

Return on Assets(ttm)

-18.86%

Income Statement

Revenue(ttm)

45.26M

Revenue Per Share(ttm)

1.21

Gross Profit(ttm)

45.26M

EBITDA(ttm)3

-89.86M

Net Income Available to Common(ttm)

-77.95M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

-74.14%

S&P 500 52-Week Change

10.23%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

37.38M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

225.97M

Total Cash Per Share(mrq)

6.04

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.85%

Quick Ratio(mrq)

6.18%

Book Value Per Share(mrq)

5.69

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.62

Free Cash Flow(ytd)

-23.13M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement